Published in Drug Alcohol Depend on September 23, 2009
Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend (2010) 1.41
Modafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse. Psychopharmacology (Berl) (2010) 1.19
Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates. J Pharmacol Exp Ther (2013) 1.12
R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse. Biol Psychiatry (2012) 1.12
A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J Subst Abuse Treat (2012) 1.10
Novel pharmacotherapeutic treatments for cocaine addiction. BMC Med (2011) 1.10
Agonist replacement for stimulant dependence: a review of clinical research. Curr Pharm Des (2013) 1.08
The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors. PLoS One (2011) 1.07
Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate. Pharmacol Ther (2012) 1.04
Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter. Drug Alcohol Depend (2014) 1.01
Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav (2011) 1.00
Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys. Exp Clin Psychopharmacol (2010) 0.99
Agonist replacement therapy for cocaine dependence: a translational review. Future Med Chem (2012) 0.97
Reinstatement of methamphetamine seeking in male and female rats treated with modafinil and allopregnanolone. Drug Alcohol Depend (2011) 0.90
Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opin Investig Drugs (2013) 0.89
Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease. Pharmacol Rev (2015) 0.88
Chronic modafinil effects on drug-seeking following methamphetamine self-administration in rats. Int J Neuropsychopharmacol (2011) 0.84
Monoamine transporter inhibitors and substrates as treatments for stimulant abuse. Adv Pharmacol (2014) 0.84
Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendations. Neuropharmacology (2014) 0.83
Neuroimaging and drug taking in primates. Psychopharmacology (Berl) (2011) 0.83
Interactions between modafinil and cocaine during the induction of conditioned place preference and locomotor sensitization in mice: implications for addiction. Behav Brain Res (2012) 0.82
Substance use after participation in laboratory studies involving smoked cocaine self-administration. Drug Alcohol Depend (2011) 0.79
The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humans. Pharmacol Biochem Behav (2010) 0.78
Modafinil Induces Rapid-Onset Behavioral Sensitization and Cross-Sensitization with Cocaine in Mice: Implications for the Addictive Potential of Modafinil. Front Pharmacol (2016) 0.75
A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology (2005) 3.53
Imaging dopamine's role in drug abuse and addiction. Neuropharmacology (2008) 3.28
Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA (2009) 3.04
Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration. J Exp Anal Behav (1973) 2.35
Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther (2006) 2.04
Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues. Ann Clin Psychiatry (2004) 1.98
Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology (2007) 1.97
Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil. J Pharmacol Exp Ther (2009) 1.88
New treatments for cocaine dependence: a focused review. Int J Neuropsychopharmacol (2007) 1.70
Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. Psychopharmacology (Berl) (2001) 1.53
Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers. Neuropsychopharmacology (2007) 1.53
The rate of cocaine administration alters gene regulation and behavioral plasticity: implications for addiction. J Neurosci (2004) 1.51
Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend (2003) 1.50
An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol (2000) 1.49
Study of the addictive potential of modafinil in naive and cocaine-experienced rats. Psychopharmacology (Berl) (2002) 1.40
Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology (Berl) (1996) 1.31
Guidelines and methodological reviews concerning drug abuse liability assessment. Drug Alcohol Depend (2003) 1.30
Glutamatergic agents for cocaine dependence. Ann N Y Acad Sci (2003) 1.21
The effects of escalating doses of smoked cocaine in humans. Drug Alcohol Depend (2003) 1.16
Modafinil and cocaine interactions. Am J Drug Alcohol Abuse (2006) 1.14
Discriminative-stimulus effects of modafinil in cocaine-trained humans. Drug Alcohol Depend (2002) 1.13
Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy. Clin Neuropharmacol (2000) 1.10
Modafinil effects in multiple sclerosis patients with fatigue. J Neurol (2009) 1.01
A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue. J Palliat Med (2009) 0.99
Self-administration of cocaine by humans: choice between smoked and intravenous cocaine. J Pharmacol Exp Ther (1992) 0.98
Acute behavioral and physiological effects of modafinil in drug abusers. Behav Pharmacol (2002) 0.98
A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study. J Clin Psychiatry (2006) 0.93
Clinical applications of modafinil in stimulant abusers: low abuse potential. Am J Addict (2002) 0.92
Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants. Ann Pharmacother (2007) 0.81
New drugs for the treatment of attention-deficit/hyperactivity disorder. Expert Opin Emerg Drugs (2004) 0.81
Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry (2007) 2.90
Prefrontal-striatal pathway underlies cognitive regulation of craving. Proc Natl Acad Sci U S A (2010) 2.89
Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. Pain (2013) 2.58
Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories. J Bacteriol (2010) 2.36
Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology (2004) 2.24
eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206. Cancer Res (2011) 2.10
Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology (2004) 2.09
The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) (2001) 2.02
Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology (2007) 1.97
"Spice" and "K2" herbal highs: a case series and systematic review of the clinical effects and biopsychosocial implications of synthetic cannabinoid use in humans. Am J Addict (2012) 1.90
Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans. Biol Psychiatry (2010) 1.75
Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. MBio (2011) 1.64
Explaining the escalation of drug use in substance dependence: models and appropriate animal laboratory tests. Pharmacology (2007) 1.62
Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology (2006) 1.56
Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology (Berl) (2007) 1.53
Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts. Drug Alcohol Depend (2009) 1.53
Comparison of smoked marijuana and oral Delta(9)-tetrahydrocannabinol in humans. Psychopharmacology (Berl) (2002) 1.47
Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. J Acquir Immune Defic Syndr (2007) 1.44
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addict Biol (2008) 1.41
Mycobacterium tuberculosis and the host response. J Exp Med (2005) 1.40
Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates? Horm Behav (2009) 1.37
MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis. Mol Cancer Ther (2011) 1.33
A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend (2005) 1.31
Acute physiological and behavioral effects of intranasal methamphetamine in humans. Neuropsychopharmacology (2007) 1.26
Effects of oral THC maintenance on smoked marijuana self-administration. Drug Alcohol Depend (2002) 1.24
Nefazodone decreases anxiety during marijuana withdrawal in humans. Psychopharmacology (Berl) (2002) 1.22
Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking. Psychopharmacology (Berl) (2012) 1.21
Pharmacotherapy for cannabis dependence: how close are we? CNS Drugs (2009) 1.19
Reinforcing effects of oral Delta9-THC in male marijuana smokers in a laboratory choice procedure. Psychopharmacology (Berl) (2005) 1.18
Sleep quality deteriorates over a binge--abstinence cycle in chronic smoked cocaine users. Psychopharmacology (Berl) (2005) 1.17
Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers. Neuropsychopharmacology (2006) 1.16
The effects of escalating doses of smoked cocaine in humans. Drug Alcohol Depend (2003) 1.16
Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. Drug Alcohol Depend (2010) 1.15
Regulation of craving by cognitive strategies in cigarette smokers. Drug Alcohol Depend (2009) 1.14
Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology (Berl) (2005) 1.13
Cocaine users differ from normals on cognitive tasks which show poorer performance during drug abstinence. Am J Drug Alcohol Abuse (2008) 1.13
Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Neuropsychopharmacology (2013) 1.13
Neurophysiological and cognitive effects of smoked marijuana in frequent users. Pharmacol Biochem Behav (2010) 1.13
Mycobacterium tuberculosis ESAT-6 exhibits a unique membrane-interacting activity that is not found in its ortholog from non-pathogenic Mycobacterium smegmatis. J Biol Chem (2012) 1.12
Gender effects following repeated administration of cocaine and alcohol in humans. Subst Use Misuse (2005) 1.11
Opioid antagonism enhances marijuana's effects in heavy marijuana smokers. Psychopharmacology (Berl) (2010) 1.11
Interaction between naltrexone and oral THC in heavy marijuana smokers. Psychopharmacology (Berl) (2002) 1.10
Intranasal cocaine in humans: effects of sex and menstrual cycle. Pharmacol Biochem Behav (2006) 1.09
Attentional bias towards cocaine-related stimuli: relationship to treatment-seeking for cocaine dependence. Am J Drug Alcohol Abuse (2007) 1.09
Response to cocaine, alone and in combination with methylphenidate, in cocaine abusers with ADHD. Drug Alcohol Depend (2005) 1.08
Residual effects of intranasal methamphetamine on sleep, mood, and performance. Drug Alcohol Depend (2007) 1.07
Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. Neuropsychopharmacology (2013) 1.06
A survey of synthetic cannabinoid consumption by current cannabis users. Subst Abus (2014) 1.06
Utility of lead-in period in cocaine dependence pharmacotherapy trials. Drug Alcohol Depend (2005) 1.06
A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) (2011) 1.06
Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse. Psychopharmacology (Berl) (2010) 1.06
Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status. Biol Psychiatry (2012) 1.05
Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana. Exp Clin Psychopharmacol (2009) 1.05
Marijuana neurobiology and treatment. Subst Abus (2008) 1.05
Aripiprazole maintenance increases smoked cocaine self-administration in humans. Psychopharmacology (Berl) (2011) 1.04
Psychosis associated with modafinil and shift work. Am J Psychiatry (2005) 1.04
Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study. Biol Psychiatry (2012) 1.03
Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users. J Clin Exp Neuropsychol (2007) 1.03
Relationship between rate of infusion and reinforcing strength of oxycodone in humans. J Opioid Manag (2009) 1.03
Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine. Neuropsychopharmacology (2009) 1.02
Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction (2012) 1.00
Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers. Addict Biol (2012) 0.99
Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. Int Rev Psychiatry (2009) 0.98
Effects of the NMDA antagonist memantine on human methamphetamine discrimination. Psychopharmacology (Berl) (2002) 0.98
Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend (2004) 0.98
Cardiovascular and subjective effects of repeated smoked cocaine administration in experienced cocaine users. Drug Alcohol Depend (2009) 0.98
Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907. Neuropsychopharmacology (2012) 0.97
The effects of oral micronized progesterone on smoked cocaine self-administration in women. Horm Behav (2010) 0.97
Using a novel alternative to drug choice in a human laboratory model of a cocaine binge: a game of chance. Drug Alcohol Depend (2010) 0.97
Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology (2013) 0.97